BDF
DXCM icon

Balasa Dinverno & Foltz’s DexCom DXCM Stock Holding History

Balasa Dinverno & Foltz’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,008
Closed -$224K – 344
2022
Q2 		$224K Sell
3,008
-536
-15% -$48.9K 0.01% 312
2022
Q1 		$453K Sell
3,544
-292
-8% -$31.9K 0.03% 208
2021
Q4 		$515K Buy
3,836
+8
+0.2% +$1.15K 0.03% 198
2021
Q3 		$523K Sell
3,828
-128
-3% -$16.1K 0.04% 191
2021
Q2 		$422K Sell
3,956
-468
-11% -$44.9K 0.03% 207
2021
Q1 		$397K Sell
4,424
-240
-5% -$22.5K 0.03% 200
2020
Q4 		$431K Sell
4,664
-844
-15% -$75.4K 0.04% 183
2020
Q3 		$568K Sell
5,508
-1,900
-26% -$199K 0.05% 144
2020
Q2 		$751K Buy
7,408
+3,348
+82% +$299K 0.08% 103
2020
Q1 		$273K Buy
+4,060
New +$253K 0.03% 198

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Balasa Dinverno & Foltz's DXCM Position: Q3 2022 in Review

Balasa Dinverno & Foltz sold out of DexCom (DXCM) in Q3 2022, closing a stake of 3,008 shares — an estimated $224K sold.

Balasa Dinverno & Foltz first reported a position in DXCM in Q1 2020 and held it in 10 quarters. The position peaked at $751K in Q2 2020. 794 funds tracked by Wall St. Rank hold DXCM as of Q3 2022.

  • Balasa Dinverno & Foltz reported no remaining DexCom position as of Q3 2022 after selling out during the quarter.
  • Balasa Dinverno & Foltz sold 3,008 DexCom shares in Q3 2022, an estimated $224K.
  • Balasa Dinverno & Foltz first reported a position in DexCom in Q1 2020 and held it in 10 quarters.
  • Balasa Dinverno & Foltz's DexCom position peaked at $751K in Q2 2020.
  • 794 funds tracked by Wall St. Rank held DexCom as of Q3 2022.

Based on Balasa Dinverno & Foltz's 13F filing for Q3 2022, filed 25 Oct 2022.